Profile
Christopher J.
DeRespino worked as an Executive Director of Business Development at Amgen, Inc. from 2018 to 2021.
Prior to that, he worked as a Director of Business Development at Onyx Pharmaceuticals, Inc. He also briefly served as the Chief Financial, Accounting & Business Officer at Adverum Biotechnologies, Inc. in 2021.
DeRespino received his undergraduate degree from The Johns Hopkins University and his MBA from The Leonard N Stern School of Business.
Former positions of Christopher J. DeRespino
Companies | Position | End |
---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Director of Finance/CFO | 2021-08-26 |
AMGEN INC. | Corporate Officer/Principal | 2021-01-31 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
Training of Christopher J. DeRespino
The Leonard N Stern School of Business | Masters Business Admin |
The Johns Hopkins University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
AMGEN INC. | Health Technology |
Private companies | 1 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Stock Market
- Insiders
- Christopher J. DeRespino